PHA ACE2 amplification

Target ACE2, Spike protein

32469114 2020. An update on ACE2 amplification and its therapeutic potential.
32700580 2020. Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety.
32729248 2020. In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
32752138 2020. Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation.
32760206 2020. Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.
32928868 2020. Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.
33204291 2020. Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.
33251800 2020. A Novel Angiotensin Converting Enzyme 2 (ACE2) Activating Peptide: A Reflection of 10 Years of Research on a Small Peptide Ile-Arg-Trp (IRW).
32735768 2020. Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.
33254514 2020. Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19.